China Industrial Biotechnology white paper released: 50% of invention patents are protected in China

Source: Bio exploration December 11, 2015, the Eighth China Industrial Biotechnology Development Summit Forum opened in Tianjin Airport Economic Zone, attracting more than 400 academicians, industry experts and business leaders from all over the country The forum studied and released the white paper 2015 on China's industrial biotechnology 》It shows the recent progress and achievements of China's industrial biotechnology in basic research, application research, technology transformation and industrial development, reflects the current situation and trend of China's industrial biotechnology development, and attracts wide attention of participants According to the white paper 2015 on China's industrial biotechnology, from 2012 to 2014, the number of China's industrial biotechnology invention patents grew rapidly, taking the lead in the world In 2012-2014, there were 28154 patents for industrial biotechnology invention in the world, half of which (14862) were protected in China According to the statistics of the distribution of patent family members, among all patent families, China's invention patents account for the highest share, reaching 31%, which is two times of the second U.S patent The number of Chinese invention patents of industrial biotechnology from Chinese patentees shows a rapid growth trend Among them, in 2014, 82.5% of China's invention patents for industrial biotechnology came from Chinese patentees, reaching a new high in recent years In addition, China is also in the international leading position in the field of industrial biotechnology related research From 2012 to 2014, there were 19797 papers published by global scholars in the specialized representative journals in the field of industrial biotechnology, 5114 papers published by China, ranking first in the world, and 4019 papers published by the United States, ranking second The total number of documents issued by the two countries accounts for 46.1% of the global total, with a significant quantitative advantage At present, China's industrial biotechnology development has a certain industrial pattern, with significantly enhanced independent innovation capacity and production technology level, which has greater advantages in fermentation products, biochemical products, bio based materials, bioenergy, etc Tianjin Institute of industrial biotechnology, Chinese Academy of Sciences, has proposed a new way to synthesize succinic acid, a chemical raw material, for the first time in the world This technology patent has been transferred to a Shandong enterprise It is expected to build the world's largest industrial production line next year.